Kaohsiung Chang Gung Memorial Hospital
Kaohsiung City, 83301, Taiwan
NCT Number: NCT04552938
The correlation between oxidative stress and increased lymphedematous limb volume lacks supporting evidence. Lymphedema patients are prone to cellulitis. This study aims to investigate the link between oxidative stress, limb volume, and cellulitis after supermicrosurgical lymphaticovenous anastomosis (LVA).
Looking for future studies?
Notify Me20 year–100 year
All sexes
Observational
Kaohsiung City, 83301, Taiwan
In this study, we focused on the changes in serum antioxidant biomarkers before and after LVA, detected by isobaric tags for relative and absolute quantitation (iTRAQ)-based quantitative proteomic analysis, enzyme-linked immunosorbent assay (ELISA), and Oxidative Stress Panel Kit. For clinical correlation, magnetic resonance (MR) volumetry was implemented for precise lymphedematous limb volume measurements. Correlations were made between changes in oxidative stress, limb volume, and cellulitis before and after LVA.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Venous serum samples were collected from patients before LVA.
Venous serum samples were collected from patients one-month after LVA.
Time frame: 6 months after surgery
The primary outcome was determined whether post-LVA volume reduction < 40%
Chang Gung Memorial Hospital
Other
The Impact of Lymphaticovenous Anastomosis on Serum Profiling in Patients With Lymphedema
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07414615
Hemic and Lymphatic Diseases, Lymphatic Diseases
Istanbul, Turkey (Türkiye)
View Trial DetailsNCT06905639
Behavior, Breast Diseases
Ponferrada, León, Spain
View Trial DetailsNCT02506530
Breast Diseases, Breast Neoplasms
Toulouse, Midi Pyrenees, France
View Trial DetailsNCT07612865
Cardiovascular Diseases, Cervical Cancer
Ürümqi, Xinjiang Uygur Autonomous Region, China
View Trial Details